Doxazosin
- Product NDC
- 50090-2153
- 11-digit product format
- 500902153
- Labeler code
- 50090
- Product ID
- 50090-2153_e184efc2-7240-4202-9778-f8d9d1fdf9ca
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxazosin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA202824
- Marketing category
- ANDA
- Marketing start
- 2015-03-04
- Substance
- DOXAZOSIN MESYLATE
- Active strength
- 1 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Doxazosin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DOXAZOSIN MESYLATE | 1 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 86P6PQK0MU |
| Rxcui | 197625, 197626, 197627, 197628 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-2153-0 | Doxazosin | 30 in 1 BOTTLE | TABLET | 30 | | 43 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-2153 | DOXAZOSIN TABLET [A-S MEDICATION SOLUTIONS] | 43 | Current NDC, Legacy NDC, 1 package rows | 20241025_4034fb6d-f55d-4df0-b500-d6a413591f6e.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-2153-0 | 50090215300 | 30 TABLET in 1 BOTTLE (50090-2153-0) | 30 tablet | 2015-10-21 | 0000-00-00 | No | No | Current |